Genetic studies in Alzheimer's disease with an NACP/alpha-synuclein polymorphism
- PMID: 8773602
- DOI: 10.1002/ana.410400212
Genetic studies in Alzheimer's disease with an NACP/alpha-synuclein polymorphism
Abstract
The non-Abeta component of Alzheimer's disease amyloid (NAC) is copurified with amyloid from the brain tissue of Alzheimer's disease victims and is immunohistochemically localized to amyloid fibrils. NAC is a hydrophobic peptide fragment from the NAC precursor protein (NACP/alpha-synuclein) that is localized to presynaptic terminals. We used a polymorphic dinucleotide repeat sequence in a genomic clone of NACP for genetic association and linkage studies. Screening of Alzheimer's disease families failed to establish linkage between NACP and Alzheimer's disease. Nevertheless, one of the NACP polymorphisms (NACP allele 2) was shown to have significant association with healthy elderly control individuals with apolipoprotein E risk. This may indicate a possible protective function of the allele.
Similar articles
-
Failure to replicate a protective effect of allele 2 of NACP/alpha-synuclein polymorphism in Alzheimer's disease: an association study.Ann Neurol. 1998 Aug;44(2):278-81. doi: 10.1002/ana.410440223. Ann Neurol. 1998. PMID: 9708555
-
Aluminum-induced structural alterations of the precursor of the non-A beta component of Alzheimer's disease amyloid.Arch Biochem Biophys. 1997 Aug 15;344(2):325-34. doi: 10.1006/abbi.1997.0207. Arch Biochem Biophys. 1997. PMID: 9264546
-
NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded.Biochemistry. 1996 Oct 29;35(43):13709-15. doi: 10.1021/bi961799n. Biochemistry. 1996. PMID: 8901511
-
[Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].Recenti Prog Med. 2002 Sep;93(9):489-97. Recenti Prog Med. 2002. PMID: 12355988 Review. Italian.
-
Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins.J Struct Biol. 2000 Jun;130(2-3):300-9. doi: 10.1006/jsbi.2000.4262. J Struct Biol. 2000. PMID: 10940234 Review.
Cited by
-
Multi-Loop Model of Alzheimer Disease: An Integrated Perspective on the Wnt/GSK3β, α-Synuclein, and Type 3 Diabetes Hypotheses.Front Aging Neurosci. 2019 Jul 31;11:184. doi: 10.3389/fnagi.2019.00184. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31417394 Free PMC article.
-
The PD-associated alpha-synuclein promoter Rep1 allele 2 shows diminished frequency in restless legs syndrome.Neurogenetics. 2014 Aug;15(3):189-92. doi: 10.1007/s10048-014-0407-z. Epub 2014 May 27. Neurogenetics. 2014. PMID: 24863655
-
Interaction of apolipoprotein E epsilon 4 with other genetic and non-genetic risk factors in late onset Alzheimer disease: problems facing the investigator.Neurochem Res. 1998 Mar;23(3):369-76. doi: 10.1023/a:1022461601609. Neurochem Res. 1998. PMID: 9482249 Review.
-
alpha-Synuclein promoter RsaI T-to-C polymorphism and the risk of Parkinson's disease.J Neural Transm (Vienna). 2006 Oct;113(10):1425-33. doi: 10.1007/s00702-006-0435-4. Epub 2006 Apr 11. J Neural Transm (Vienna). 2006. PMID: 16604306
-
Interaction between α-Synuclein and Bioactive Lipids: Neurodegeneration, Disease Biomarkers and Emerging Therapies.Metabolites. 2024 Jun 22;14(7):352. doi: 10.3390/metabo14070352. Metabolites. 2024. PMID: 39057675 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical